Cryptosporidiosis
ICD-10 A07.2 · ICD-11 1A32

Treatment of Cryptosporidiosis in Patients with a Weakened Immune System, Including HIV Infection

Cryptosporidiosis poses a heightened clinical challenge in patients whose immune defences are compromised. In this population — particularly those living with HIV — the infection tends to be more severe and more prolonged than in immunocompetent individuals.

Clinical scenario

Patients with a weakened immune system, including those with HIV infection, are at higher risk of severe and prolonged illness from Cryptosporidiosis. Restoring immune function is a central consideration in managing the infection in this group.

Treatment approach (partial)

In patients with HIV, the approach centres on immune reconstitution alongside supportive measures to prevent dehydration. A specific anti-infective agent may also be considered, though its benefit in the immunocompromised setting remains uncertain.

Full regimen details, sequencing, and clinical decision points are in the structured protocol below.

Treatment goal

Decrease or elimination of cryptosporidiosis diarrhea.

References

  • People with weakened immune systems are at higher risk of more severe and prolonged illness.
  • For people infected with HIV, anti-retroviral therapy can rebuild the immune system, which can decrease or eliminate symptoms of cryptosporidiosis.
  • Cryptosporidiosis can be managed by drinking plenty of fluids to prevent dehydration.
View source ↗